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Abstract
Background: Locating technologies are a subtype of assistive technology that aim to support persons with
dementia by helping manage spatial orientation impairments and provide aid to care partners by intervening when
necessary. Although a variety of locating devices are commercially available, their adoption has remained low in the
past years. Several studies have explored barriers to the adoption of assistive technologies from the perspective of
professional stakeholders, but in-depth explorations for locating technologies are sparse. Additionally, the inputs of
business professionals are lacking. The aim of this study was to expand knowledge on barriers to the adoption of
locating technologies from a multi-stakeholder professional perspective, and to explore strategies to optimize
adoption.
Methods: In total, 22 professionals working in business (n = 7), healthcare (n = 6) and research (n = 9) fields related
to gerontology and gerontechnology participated in our focus group study. Perceptions on the value of using
locating technologies for dementia care, barriers to their adoption, as well as salient services and information
dissemination strategies were explored. After verbatim transcription, transcripts were analysed following an
inductive data-driven content analysis approach in MAXQDA.
Results: Six key adoption barriers centering on: (1) awareness-, (2) technological-, (3) product characteristic- and (4)
capital investment-based limitations, (5) unclear benefits, as well as (6) ethical concerns emerged. The interplay
between barriers was high. Five core themes on services and information dissemination strategies centering on: (1)
digital autonomy support, (2) emergency support, (3) information dissemination actors, (4) product acquisition, and
(5) product advertising were extracted.
Conclusions: Our study with interdisciplinary stakeholders expands knowledge on barriers to the adoption of
locating technologies for dementia care, and reinforces recommendations that an interdisciplinary strategy is
needed to optimize adoption. Also, our findings show that focusing on services to increase digital autonomy and
on information dissemination strategies has been largely overlooked and may be particularly effective.
Keywords: Alzheimer’s disease, Assistive technology, Adoption, Barriers, Dementia, Focus group, Locating
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Background
The development and deployment of assistive technolo-
gies (ATs) represents an opportunity to reshape demen-
tia care on a global and socioeconomically diverse scale
at potentially low costs [1]. Several types of ATs exist to
compensate for a multitude of cognitive and physical
deficits in persons with Alzheimer’s disease (AD) and re-
lated dementias [2]. In the literature, locating, or ‘moni-
toring’, ‘surveillance’, ‘tracking’, or ‘wayfinding’ ATs that
use satellite-based positioning technology such as global
position systems (GPS) have received considerable atten-
tion [3, 4]. Indeed, spatial orientation impairments in
AD develop early [5], are common [6, 7], and can cause
significant stress and burden for persons with dementia
and their care partners [8]. Prevalence rates of persons
with dementia getting lost even in familiar environments
range from 17% [6] to 75% [7] depending on definitions
and reporting measures used, which exposes persons
with dementia to risks that can result in life-threatening
circumstances [9]. To avoid such risks, care partners
often limit independent outdoor ambulation by opting
for chaperon, sedative or incarceration-type prevention
measures [10] although these measures can negatively
impact biopsychosocial health [11]. By contrast, locating
devices can promote the independence and safety of per-
sons with dementia by helping manage spatial orienta-
tion impairments and by supporting care partners to
intervene when necessary [12].
To date, acceptability studies with different stake-
holders including persons with dementia and care part-
ners (hereafter end-users), as well as with healthcare and
research professionals report favorable perceptions on
the appropriateness and openness of using locating tech-
nologies for dementia care [13, 14]. Yet, outside research
environments, end-users generally have little awareness
of the existence of these technologies [15, 16]. Conse-
quently, adoption rates remain low [17, 18] despite the
increasing availability of commercial products [12]. Simi-
lar findings have been reported for the broader category
of ATs [15], which has resulted in the exploration of
adoption barriers by these stakeholders [13, 14, 19]. Pre-
dominant ATs adoption barriers include awareness-,
translational-, effectiveness-, ethical-, and structural-
based barriers [14], as well as cost factors [20]. However,
very few studies have specifically focused on locating
technologies. As such, key factors affecting their adop-
tion might be overlooked [21]. For example, to our
knowledge at least one community-based Norwegian
study has examined the factors affecting the successful
deployment of GPS technologies for public dementia
care services, and reports that early adoption in the
course of AD is critical [22]. Early adoption has also
been highlighted as a central factor affecting product us-
ability and long-term adoption in a Canadian-based
study [23]. Certainly, additional studies in different cul-
tural backgrounds are warranted. Also, successful adop-
tion might not strongly depend on early intervention for
other ATs.
In addition, existing studies have largely overlooked
the voices of business stakeholders intimately involved
in product design, development, and commercialization
although their inclusion has been recommended [24].
The low involvement of business professionals in past
research could help explain the paucity of recommenda-
tions on which services [25] should be offered to end-
users and which information dissemination approaches
such as marketing strategies [26] should be utilized to
help maximize end-user awareness, positive user experi-
ence (UX), and product adoption [26, 27]. Examples of
services such as customer support including product
training and technical support in emergency situations
have been identified as central needs by end-users [19,
28]. In research settings, these needs are also recognized
by researchers as end-users typically receive study-
developed product manuals and product training. Still, it
remains unclear how to effectively reach and support
end-users outside research settings.
Using insights from focus groups with key stake-
holders from business, healthcare and research fields,
the current study complements existing research by pro-
viding an in-depth exploration of the adoption barriers,
and recommendations for salient services and informa-
tion dissemination strategies for locating technologies
for dementia care. The goal was to identify ways to




We utilised a purposive sampling technique to recruit
professionals working in fields related to gerontology
and gerontechnology from our work network. In total,
seventy professionals were contacted via personalized e-
mail to partake in a half-day focus group study held at
the Memory Clinic of the Charité Universitätsmedin
Berlin, Germany, in May 2016. Invitations outlined the
study purpose, methodology and organizational details.
Specifically, professionals were from business fields
within the technology industry sector (representatives of
ATs companies with current gerontechnology focus in-
cluding company executives and executive associates,
marketing analysts, UX designers, and software devel-
opers), healthcare fields (representatives of Alzheimer
societies, community organisations serving older adults
with disabilities and nursing homes including local com-
munity representatives, managing directors, healthcare
managers, social workers, gerontologist, as well as edu-
cation and program coordinators), as well as research
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fields (research associates, project managers, group
leaders, as well as postdoctoral and doctoral researchers
from the fields of gerontology, rehabilitation sciences,
social work, health services administration, medical soci-
ology and rehabilitation science, nursing sciences, and
gerontechnology). To maximize group homogeneity and
interaction [29], professionals were separated into
groups based on their professional field. We estimated
that sample sizes per group of approximately ten to fif-
teen would be sufficient to reach data saturation based
on sample homogeneity [29]. All professionals who par-
ticipated provided their written informed consent, and
the ethics committee of the medical faculty of the Char-
ité Universitätsmedizin Berlin approved of the study
(protocol number EA4/033/16). Participation was volun-
tary, there were no exclusion criteria, and no incentives
for participation were provided. To help ensure that pro-
fessionals felt comfortable when sharing their thoughts
and experiences, discussion moderators indicated that
each participant would be given a unique identification
number known only to the research team when coding
raw data. All methods were carried out in accordance
with relevant guidelines and regulations.
Study design
A qualitative study in the form of focus groups to obtain
information from various viewpoints [30] was per-
formed. To inform the study design, we employed a
qualitative description methodology [31]. Qualitative de-
scription is particularly helpful to gain an in-depth un-
derstanding of healthcare-related topics and useful
“because of its ability to provide clear information on
how to improve practice” (p. 2) [31]. To identify topics
and structure the focus group, an interview guide based
on a review of the relevant literature was developed [13–
20, 28, 30–32]. The final guide comprised of three sec-
tions detailed below. Each group was led by a discussion
moderator (HM, OP, LW) and one or two assistant
moderators (SDF, VL, RS, GÖ, FK) who kept notes and
audio recorded the discussion. All moderators and as-
sistant moderators were provided with the interview
guide prior to the focus groups. Also, a dry run of the
interview guide was performed to allow for adjustments
in wording or placement of questions, and to ensure fa-
miliarity and consistency with the guide between groups.
Focus groups lasted approximately three hours, which
included the administration of informed consent and fill-
ing out of questionnaires.
Section 1: exploration of perceptions on value of use
Professionals first filled out a standard demographic
questionnaire which also assessed years of experience
(i.e., professional or personal) with dementia and ATs, as
well as one-time and monthly pay willingness for a
locating device from the perspective of end-users (i.e.,
proxy measurement). Also, technological affinity was
assessed with the Technological Affinity for Electronic
Products questionnaire (TA-EG; Likert scale 19–95,
scores proportional to affinity) [33]. The TA-EG assesses
key aspects of the technology acceptance model which
provides information on technology acceptance and use
[34]. Then, professionals’ perceptions on the value of
using locating technologies for dementia care were ex-
plored by having them write down and discuss at least
two keywords or phrases they associate with their use.
Exploring perceptions served as an icebreaker [32] to
allow professionals to acclimatise to their group before
moving onto the next sections.
Section 2: exploration of adoption barriers
Thereafter, obstacles to the adoption of locating tech-
nologies by end-users were explored by examining views
on personal experience, product characteristics, and clin-
ical needs and expectations. To supplement the discus-
sion, a GPS watch marketed for persons with orientation
impairments and a smartphone with a pre-installed na-
tive android application to locate the watch were pre-
sented. These products were available due to our
concurrent UX study with persons with dementia and
care partners [12], and are displayed in more detail [see
Additional file 1].
Section 3: exploration of services and information
dissemination strategies
Lastly, views on salient services and information dissemin-
ation strategies, including recommendations for customer
services, service provision methods, and promotional
methods such as product advertising were discussed. To
supplement the discussion, the flyers of two commercially
available GPS watches marketed for persons with orienta-
tion impairments [12], which included the GPS watch
shown in the previous section, were presented.
Data analysis
Audio data were digitally recorded, and transcribed verba-
tim (SDF, HM, CH) into MAXQDA [35]. Afterwards,
transcripts were cross-checked with the recordings to en-
sure validity (SDF, HM, CH). Transcripts were thematic-
ally analysed (SDF, HM, CH) using content analysis that
followed a data-driven inductive data analysis method
[36]. First, common patterns and themes were independ-
ently identified and chunked into thematic codes while
staying as close to the transcripts as possible. Any unclear
quotes and counter-arguments were also noted. Then,
codes were further refined into subthemes, and lastly dis-
cussed during multiple meetings until team consensus
(SDF, HM, CH) was reached to ensure reliability. Data sat-
uration was also assumed to be reached, as no new
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information could be added to the codes. All authors
reviewed and discussed the final codes.
Written perceptions from the first section of the focus
groups provided the opportunity to obtain opinions
from all participants. As such, a theme density (i.e.,
number of times a theme arose), supplemented by con-
tributions in the open discussion, was calculated for this
section. Reporting of qualitative data using the COREQ
(COnsolidated criteria for REporting Qualitative re-
search) Checklist [37] is displayed in more detail [see
Additional file 2]. Quantitative data were analysed by
performing descriptive statistics. Potential group
differences based on group membership or gender were
compared with Kruskal Wallis or Mann-Whitney tests,
as appropriate. Statistical significance was set at P-value
< 0.05 using IBM SPSS Statistics, version 23 [38].
Results
Participant characteristics
In total, 22 professionals out of the 70 contacted partici-
pated (n = 35, no response; n = 8, unavailable; n = 5, no-
show). The final groups were: (i) business (n = 7, with n = 3
company executives, n = 1 executive associate, n = 1 soft-
ware developer, n = 1 marketing analyst, and n = 1 UX de-
signer) (ii) healthcare (n = 6, with n = 1 social worker, n = 1
gerontologist, n = 2 managing directors of AD societies, and
n = 2 healthcare managers of community organisation serv-
ing older adults with disabilities), and (iii) research (n = 9,
with n = 1 postdoc (gerontology), n = 3 PhD students (ger-
ontology, rehabilitation sciences, and medical sociology and
rehabilitation science), n = 3 project managers (health ser-
vices administration, and two gerontology), and n = 2 re-
search associates (both gerontechnology). No significant
group membership differences were found. One significant
difference between gender and dementia experience was
found, Mann-Whitney U = 20.500, z = − 2.681, P = .007,
with a mean rank of 7.55 for males and 14.79 for females.
Participant demographics are presented in Table 1.
Perceptions of value of use
We identified three recurrent themes on perceptions on
value of use and nine subthemes, displayed in Table 2,
Table 1 Descriptive characteristics of the participants
Variables Business (n = 7) Healthcare (n = 6) Research (n = 9) All (n = 22)a
Age 44.3 ± 10 [32–55] 46.7 ± 12.9 [28–62] 37.1 ± 11.1 [27–62] 42 ± 11.5 [27–62]
Gender, m/f (female) 5/2 (29) 2/4 (67) 3/6 (67) 10/12 (55)
Education, n
High school 1 (14) 1 (17) – 2 (9)
College 1 (14) 1 (17) – 2 (9)
Any universityb 5 (71) 4 (67) 9 (100) 18 (82)
Dementia exp. yrs., n
< 2 yrs 1 (14) – 4 (44) 5 (23)
2–5 yrs 4 (57) 1 (17) – 5 (23)
5–10 yrs 2 (29) 2 (33) 2 (22) 6 (27)
> 10 yrs – 3 (50) 3 (33) 6 (27)
ATs exp. yrs., n
< 2 yrs 1 (14) 1 (17) 4 (44) 6 (27)
2–5 yrs 3 (43) 2 (33) 1 (11) 6 (27)
5–10 yrs 3 (43) 2 (33) 4 (44) 9 (41)
> 10 yrs – 1 (17) 1 (5)
Pay willingness, once 235.6 ± 134.6 [99–500] 255 ± 193.8 [100–600] 211.7 ± 176.6 [20–500] 231.1 ± 162.3 [20–600]
Pay willingness, monthly 16.3 ± 8.2 [5–30] 20.5 ± 8.1 [10–30] 17.9 ± 17.6 [0–50] 18.1 ± 12.5 [0–50]
TA-EG (range 19–95) 76.6 ± 8.7 [59–83] 64.7 ± 6.7 [58–74] 68 ± 9.9 [57–83] 69.7 ± 9.7 [54–83]
Abbreviations: ATs assistive technologies, exp. experience, m/f male/female, n number, TA-EG Technological Affinity for Electronic Products, yrs. years
Continuous and discrete variables are displayed as mean ± standard deviation [range].
Standard deviations are rounded to nearest decimal point. Percentages are rounded to nearest whole number. TA-EG scores are proportional to technological
affinity. Pay willingness in Euros.
aBusiness group: n = 3 company executives, n = 1 executive associate, n = 1 software developer, n = 1 marketing analyst, and n = 1 UX designer; healthcare group:
n = 1 social worker, n = 1 gerontologist, n = 2 managing directors of AD societies, and n = 2 healthcare managers of community organisation serving older adults
with disabilities; research group: n = 1 postdoc (gerontology), n = 3 PhD students (gerontology, rehabilitation sciences, and medical sociology and rehabilitation
science), n = 3 project managers (health services administration, and two gerontology), and n = 2 research associates (both gerontechnology).
bFor education, “any university”: one business, healthcare and research professional, respectively, obtained a Master’s degree, and four business, three healthcare
and eight research professionals obtained a PhD degree.
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Table 2 Overview of themes and subthemes illustrated with quotes per focus group section
Section 1: Exploration of perceptions on value of use





• Location finding P2, Business, Company executive: “Security is guaranteed by the
product since for example, when persons with dementia do not come







• Risk reduction P2, Business, Company executive: “A lot of people have been saved
with these products from freezing, drowning, etc.”
Counterargument • False sense of security P15, Research, PhD student (gerontology): “I can see with the app
where a person with dementia is, on which street corner, but I can’t see
whether s/he is crossing at a red light or not.”
nb = 0 (0)






• Autonomous mobility P15, Research, PhD student (gerontology): “These products can also
help maintain or increase the freedom of movement and independence
of persons with dementia.”
P6, Business, Company executive: “If you don’t have such a system,
then you have someone telling persons with dementia: “Stop” Stay put!







• Social engagement P15, Research, PhD student (gerontology): “Yeah I mean like when you
can see a daily profile of persons with dementia—where one likes to go,
spend their time, what they find interesting in their neighbourhood.”
Counterargument • Feeling tracked P5, Business, Marketing analyst: “The persons that wears the product











• Assistance with remote location
• Efficient resource utilization
• Uneasiness about tracking
P2, Business, Company executive: “It makes me feel more secure
because I’m worried that my [fictitious] dad might not find his way
back home although he might be able to… We have clients come up
to us and say: ‘Thank you, thank you, thank you! We can let our father,
uncle, etc. walk alone again.”
P6, Business, Company executive: I see monitoring also positively. There
are a lot of people in professional care settings or care partners who
feel responsible in providing this monitoring.”
P22, Research, Research associate (gerontechnology): “To make it
easier to care for persons with dementia… It might be more
comfortable for formal care settings because they can save on
personnel or invest less time in these [locating] task.”
P5, Business, Marketing analyst: “But also care partners that use the










nh = 0 (0)
nr = 0 (0)
Section 2: Exploration of adoption barriers
Themes Subthemes Illustrative quotes
Awareness limitations • Low knowledge transfers between
stakeholders
• Limited information on, and access
to commercial products
• Low technological affinity of end-users
P14, Research, Postdoc (gerontology): “I can’t use what I don’t know exists. That’s
the main problem I learned after conducting 105 interviews [with persons with
dementia and care partners].”
P11, Healthcare, Managing director of AD society: “From the perspective of end-
users, this is a product that I don’t know, that is unfamiliar… Product awareness is
still largely inadequate.”
P2, Business, Company executive: “My personal opinion: Way too early. End-users
don’t know that these products exist.”
P21, Research, Research associate (gerontechnology): “General practitioners don’t
have an overview of all commercially available products. The same goes for nursing
facilities.”
P4, Business, Software developer: “If care partners need it [GPS technology], where
do they go? Where can you buy it? You won’t find it in a supermarket or media
store! You first have to research it and if you’re not from this line of work, it’s hard
[to find information].”
P14, Research, Postdoc (gerontology): “Some [persons with dementia and care
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Table 2 Overview of themes and subthemes illustrated with quotes per focus group section (Continued)
partners] say: ‘I’ve read or heard about this, but I don’t know where I can buy these
products. I guess online’.”
P18, Research, Project manager (gerontology): “There are certainly older adults
that are good with technologies, which have smartphones. But there are some older
adults that have no experience—that are technology skeptic.”
P13, Healthcare, Healthcare manager: “We are talking about the age group 70 plus,
right? The next generation will be more familiar with these technologies.”
Technological
limitations
• Unsatisfactory reliability and accuracy
of location function
• Limited functionality
P16, Research, PhD student (rehabilitation science): “If it’s in the name, it has to
work!”
P14, Research, Postdoc (gerontology): “If it [location] doesn’t work reliably, it won’t
reduce care partners stress and burden.”
P22, Research, Research associate (gerontechnology): “When one enters an
underground parking lot or a building, then you can often pretty much forget
about location. The product has to be more than 150% reliable. If not, you can
forget it!”
P22, Research, Research associate (gerontechnology): “It should be low
maintenance… You should be able to locate immediately, without having to wait
for updates. And if there’s a discrepancy of a few meters and I’m in the pedestrian
zone and there are a lot of people around, it could be that I don’t find someone
who is two meters away.”
P16, Research, PhD (rehabilitation science): “The location of two minutes ago
might not be valid.”
P11, Healthcare, Managing director of AD society: “For the battery, there’s a signal
notifying you when you are running low on power. Of course, the question is when
you receive a notification. Because it’s totally annoying if the product starts to beep
when you are alone. This might lead to more disorientation.”
P5, Business, Marketing analyst: “Geofencing is one aspect. I would program other
intelligent functions, such as integrated temperature recognition. There are maybe
other things at persons with dementias’ location that could active an alarm. So I
would program intelligent systems.”
P7, Business, UX designer: “I would like a product that notifies me when my
[fictitious] mom leaves her home without the product.”
P22, Research, Research associate (gerontechnology): “And then an emergency
recognition, so that when persons with dementia fall down or stumble on
something, that the system recognizes this.
• Poor battery performance P3, Business, Executive associate: “If I need a GPS product all day, maybe it won’t
last all day. And cellphones [for care partners] either.”
P1, Business, Company executive: “How long does the battery last? Since our latest




• Low end-user focus and product
customizability in product development
P10, Healthcare, Managing director of AD society: “A decisive factor is how easy
the different functions are to understand… Regarding product functions, less is
more.”
P12, Healthcare, Healthcare manager: “There is a person with dementia who lives
in our nursing facility. He doesn’t leave the grounds without his fanny pack. If you
could put the product in his fanny pack and it would still work, that
would be ideal.”
P16, Research, PhD (rehabilitation science): “Individual configuration... to set up a
custom area ‘from this crossroad to here’.”
P9, Healthcare, Gerontologist: “I find it good that there are different functions, such
as the emergency and two-way communication. But these functions should be indi-
vidually customizable, looking at actual severity level and other factors.”
P3, Business, Executive associate: “What dementia severity does the person have? A
one-size-fits-all product won’t work.”
P9, Healthcare, Gerontologist: “Persons developing the technology don’t involve
end-users. First of all to ask: ‘What do you want from your product? What should
the product look like?’”
P2, Business, Company executive: “Persons with dementia and care partners are
not our primary market group.”
P6, Business, Company executive: “I think I’ve realized that we have to think a lot
more from the perspective of end-users. This should always be the starting point
and then think about hardware and so forth.”
• Unsatisfactory and stigmatizing
aesthetics
P11, Healthcare, Managing director of AD society: “Most products are not
aesthetically pleasing for females.”
P10, Healthcare, Managing director of AD society: “For the design, yeah, there’s
black, but I would think of offering products in more colors. This should be possible.”
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Table 2 Overview of themes and subthemes illustrated with quotes per focus group section (Continued)
P1, Business, Company executive: “The products are too big! We would gladly
reduce the size if the technology would allow it… The problem is that you need
space for a better battery, for power, for… And so that it’s comfortable to wear,
particularly if it’s to be worn on the wrist.”
P1, Business, Company executive: “Some products have security straps. But no one
wants to walk around with such a thing!”
• Product costs P1, Business, Company executive: “The biggest barrier is always the price.”
P10, Healthcare, Managing director of AD society: “There’s a cost problem at the
moment. Can I afford this? Are there any additional costs once I use it? Products are
simply too expensive.”
P8, Healthcare, Social worker: “Cost is a big factor. Do I purchase it or not for the
last phase of my life?”
Capital investment
limitations
• Lack of funding P1, Business, Company executive: “There’s no one here [in the other groups] that I
know was involved in product development, right? There’s a big discrepancy. We
could all say how products should be and what could be done. But you have to
have the money to do this…you first have to have the money to invest.”
• Low product development follow-
through
P1, Business, Company executive: “There are too many products that are not
developed to the end.”
Unclear benefits • Unclear perceived need by
• end-users
P11, Healthcare, Managing director of AD society: “Persons with dementia do not
see that they need it [locating device]. At most, care partners recognize a need.”
P6, Business, Company executive: “I can imagine that my fictitious father might
need such a product. But whether he sees a need? There might be no recognized
need.”
P2, Business, Company executive: “No end-user purchases it out of prevention. All
buy it because something has already happened.”
P8, Healthcare, Social worker: “It [using a locating technology] of course depends
on dementia severity.
• Reliance on other trusted locating
methods
P5, Business, Marketing analyst: “I [care partners] might pragmatically get more
involved with the [local] community.”
• Lack of studies and unclear clinical
effectiveness
P21, Research, Research associate (gerontechnology): “End-users should be more
involved [in research and development]. They should test products and then we will
better understand what needs to be improved.”
P1, Business, Company executive: “We need the Charité and the German Alzheimer
Society to come out with studies. Then there will be a bigger discussion.”
P2, Business, Company executive: “There are dementia severities, and then it’s
always the question: ‘How long can I [care partners] let persons with dementia
move about and use the product [without studies with persons with dementia with
different AD severities]?”
P19, Research, Project manager (gerontology): “I can’t evaluate products as a lay
person. Do I need it? Does it work?”
• Previous negative user experience P1, Business, Company executive: “The technology is constantly changing. And
those [end-users] who did test it three-four years ago… they had bad experiences.
And if it doesn’t work on the first attempt: Next! Forget it!”
Ethical concerns • Balance between autonomous
mobility of persons with dementia
and control by care partners
• Unclear information on data privacy
and security
P19, Research, Project manager (gerontology): “As a person with dementia, I have
my autonomy, I have my rights. I might not know that I am being located at a
particular time. But for care partners, that’s really not a problem because they have
a sense of security. There’s a big difference between medical professionals and care
partners, where medical professionals say: ‘That’s an infringement on personal
freedom’, and care partners say: ‘I don’t care. I have to know where [person with
dementia] is!’”
P13, Healthcare, Healthcare manager: “There are also data security aspects, so
basically the fear of being watched or controlled.”
P3, Business, Executive associate: “I think of tracking firms that collect large
amounts of data, secretly collecting information on movement profiles… Do we
reduce independence or increase security?”
• Unclear legal rights on location of others P6, Business, Company executive: “We are very involved with this at the moment.
How many movement profiles can be programmed and saved, under which
conditions, etc.? This is a very difficult situation at the moment for all businesses
involved.”
P15, Research, PhD student (gerontology): “There are a lot of decisions at the
moment on what is allowed regarding locating others.”
P2, Business, Company executive: “Ultimately, it’s a legal problem with too many
unknowns. Are we allowed to do this, to do that? This hinders commercialization.
First get approval from a court of law. The external framework could be better. This
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Table 2 Overview of themes and subthemes illustrated with quotes per focus group section (Continued)
is one of the main reasons why it [GPS technologies] has not spread so quickly.”
Section 3: Exploration of services and information dissemination strategies
Themes Subthemes Illustrative quotes
Digital autonomy
support
• Installation and product training
support
P15, Research, PhD student (gerontology): “A support that’s really tailored to end-
users. Particularly to help set up and configure the product.”
P3, Business, Executive associate: “If I use it for the first time, I would like to have
an installation assistance on how to use the app that I can maybe turn on and off.”
P17, Research, Project manager (health services administration): “That you really
have an on-location support that also makes house calls to help one get started
with the product.”
P5, Business, Marketing analyst: “Case-management service support… If I have a
person with deficits, with a certain problem severity, then I can also offer other
attractive service support features.”
• Automated technical support P6, Business, Company executive: “…for example, that telephone numbers are
listed on a website, that frequent questions such as ‘How to install the program’,
etc. are provided.”
Counterargument • Unclear affordability of services for end-
users
P2, Business, Company executive: “But these services have to be affordable and
there are simply too many older adults that do not have the financial capacity.”
Emergency support • Emergency call centers P10, Healthcare, Managing director of AD society: “At a minimum [for emergency
situations], there has to be a hotline.”
P17, Research, Project manager (health services administration): “It’s important to
have an emergency support call service that answers whatever question you might
have.”
Counterargument • Lack of personnel and financial resources P6, Business, Company executive: “When an alarm is set out, because you have
personnel changes every 24 h, you have to have a lot of people that do this [job].
Who does it on the weekends?”
P22, Research, Research associate (gerontechnology): “Support that is available
24/7…but this has to be financed. That’s also really expensive!”
Information
dissemination actors
• Multi-actor approach: memory clinics,
medical supply stores, general
practitioners, local government, and
healthcare insurance companies
P9, Healthcare, Gerontologist: “You could involve memory clinics.”
P?, Healthcare: “It would be really easy to involve medical supply stores.”
P17, Research, Project manager (health services administration): “I think that
general practitioners should be involved because they are typically the starting
point. There’s a trust-based relationship there.”
P19, Research, Project manager (gerontology): “There’s a pilot project in [German
city], where the government has set up a counselling center also for technology for
older adults…They can advise you there…You can go to them, but they can also
go to you.”
P5, Business, Marketing analyst: “What we need is support from an established
healthcare insurancecompany that creates a ‘service-support platform’.”
Counterargument • Financial, time and lack of follow-up
limitations of proposed actors
P9, Healthcare, Gerontologist: “But persons with dementia come here [memory
clinic] at max every six months…”
P22, Research, Research associate (gerontechnology): “If my general practitioner
talks to me about such products, I’d feel like they are trying to sell me something. I
don’t go to my general practitioner for that.”
P19, Research, Project manager (gerontology): “GPs are saying: ‘What else are we
also supposed to do?’ Who pays for this extra work?”
Product acquisition • Retail options P19, Research, Project manager (gerontology): “At the moment, most products can
be bought online. So there’s a lack of vendors with whom older adults can talk to. I
think personal talks are extremely important.”
• Trial periods P8, Healthcare, Social worker: “I might see an ad for such a product and think:
‘Oh, that’s cool!’ But I still have no experience with the product. Experience is
elementary. If I don’t have experience, I won’t use the product.”
P12, Healthcare, Healthcare manager: “For me, it would be a requirement that I
can test the product first for two to three weeks without having to pay a big
amount for this. Maybe a little fee, but not the entire amount.”
P16, Research, PhD (rehabilitation science): “For many, it’s important to be able to
experience the product, to touch it, feel it. Maybe offer a trial purchase.”
• Government subsidies P5, Business, Marketing analyst: “In nursing care, there are a lot of government care
grants…different financial plans, how you can use these various services.”
Product advertising • Promotion of independence and
autonomy
P2, Business, Company executive: “We are trying to erase the word tracking.”
P3, Business, Executive associate: “We’ve replaced the word tracking with guardian
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Section 1. No differences in theme density between
groups were found. The shared perception was that
using locating technologies could result in increasing
end-users’ quality of life on psychological, social, and
physical levels by: (i) promoting the personal security
and (ii) independence of persons with dementia, and by
(iii) reducing stress and burden experienced by care
partners. These benefits could be achieved due to loca-
tion finding, risk reduction, supporting autonomous mo-
bility and social engagement, by offering peace of mind
for care partners by assisting with remote location, and
by improving caregiving resource utilization.
P2, Business, Company executive: “A lot of people
have been saved with these products from freezing,
drowning, etc.”
P15, Research, PhD student (gerontology): “Yeah I
mean like when you can see a daily profile of persons
with dementia—where one likes to go, spend their time,
what they find interesting in their neighbourhood.”
P2, Business, Company executive: “It makes me feel
more secure because I’m worried that my [fictitious] dad
might not find his way back home although he might be
able to … We have clients come up to us and say: ‘Thank
you, thank you, thank you! We can let our father, uncle,
etc. walk alone again.”
P22, Research, Research associate (gerontechnology):
“To make it easier to care for persons with dementia … It
might be more comfortable for formal care settings be-
cause they can save on personnel or invest less time in
these [locating] task.”
Table 2 Overview of themes and subthemes illustrated with quotes per focus group section (Continued)
angel.”
P10, Healthcare, Managing director of AD society (flyer-feedback): “And
particularly in old age, the importance of remaining independent without sacrificing
comfort and safety.”
P11, Healthcare, Managing director of AD society (flyer-feedback): “I prefer the
description on this flyer. It’s simple and contains all you need to know. I see security,
quality of life, liberty. The visual presentation is good, and the font size is nice and
large. This other flyer is not directed toward persons with dementia, but rather only
toward care partners.”
P19, Research, Project manager (gerontology; flyer feedback): “This picture is a no-
no for the current generation of older adults.”
• Seal of quality from trusted
organisations
P1, Business, Company executive: “There have to be institutions. That’s why I’m
here today… In the end, the Charité or similar is missing. The stamp from ISO does
not suffice. When Charité or German Healthcare Ministry is visible, then there’s a
completely different quality level that is achieved.”
• Addressing concerns of end-users:
data security, product characteristics,
and service details
P20, Research, PhD (medical sociology and rehabilitation science): “It could be a
marketing problem… for example, that it’s not clear that it can be avoided that
everyone sees my data and locate me. If I don’t know that, I don’t buy it.”
P10, Healthcare, Managing director of AD society: “This aspect [data security] has
to be covered in product advertising.”
P16, Research, PhD (rehabilitation science): “I really think that there is a general
lack of clear information on data security. It’s really important that data security is
communicated and mentioned and that it’s theoretically possible for a third party
to access data sensitive information. So that people know what to do in such
situations.”
P5, Business, Marketing analyst (flyer feedback): “What I still don’t know is whether
I have to take the watch off every day and charge it.”
P6, Business, Company executive: “Let’s say I receive a message at 4 am about my
mother and this happens three nights in a row. I’ll be woken up and I can’t really
help… What happens then?”
• Conventional advertising platforms:
television, magazines, pharmacies
P14, Research, Postdoc (gerontology): “There are probably people that don’t check
online for this [GPS product], but rather watch TV. So maybe use TV ads to multiply
information.”
P22, Research, Research associate (gerontechnology): “I saw an ad in [free
magazine with large older adult readership] about a high blood pressure product. I
thought that was really good. A magazine that a lot of older adults read—not just
persons with dementia and care partners. And the magazines are free. You can just
take one.”
P14, Research, Postdoc (gerontology): “Maybe there should just be ads placed in
pharmacy windows.”
Counterargument • Financial limitations P1, Business, Company executive: “I don’t produce million-dollar TV ads.”
Abbreviations: n number; nb business, nh healthcare, nr research
Percentages in parentheses rounded to nearest whole number
aTheme density calculated based on professionals’ written keywords or phrases and supplemented by contributions in the open discussion
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Still, professionals expressed mixed feelings for each
perceived benefit. In particular, products could represent
a sense of false security due to inaccurate location.
P15, Research, PhD student (gerontology): “I can see
with the app where a person with dementia is, on which
street corner, but I can’t see whether s/he is crossing at a
red light or not.”
Also, persons with dementia might view product use
as reducing their independence due to feelings of being
tracked. Similarly, care partners could feel uneasy when
using products due to their tracking nature.
P5, Business, Marketing analyst: “The persons that
wears the product can feel like they are being tracked,
and that’s not a good feeling.
P5, Business, Marketing analyst: “But also care part-
ners that use the product can feel uneasy because they
are tracking persons with dementia.”
However, professionals pointed out that most care
partners feel morally responsible to monitor and that de-
vices offer more ethical forms of monitoring compared
to alternative methods such as restricting ambulation.
P6, Business, Company executive: I see monitoring also
positively. There are a lot of people in professional care
settings or care partners who feel responsible in providing
this monitoring.”
P6, Business, Company executive: “If you don’t have
such a system, then you have someone telling persons
with dementia: “Stop” Stay put! Where are you going
again?”
Adoption barriers
We identified six recurrent adoption barrier themes and
18 subthemes, displayed in Table 2, Section 2.
(i) Awareness limitations. A key theme centered on
the low awareness of the existence of locating
technologies by end-users. This could be attributed
in part to poor knowledge transfers between end-
users and professional stakeholders. Business pro-
fessionals indicated product marketing issues lead-
ing to low awareness, such as products being
released “way too early”.
P14, Research, Postdoc (gerontology): “I can’t use what
I don’t know exists. That’s the main problem I learned
after conducting 105 interviews [with persons with de-
mentia and care partners].”
P2, Business, Company executive: “My personal opin-
ion: Way too early. End-users don’t know that these prod-
ucts exist.”
Also, the lack of a readily available overview of com-
mercial products, and limited retail access to products
leading to complex purchasing processes for end-users
were highlighted.
P21, Research, Research associate (gerontechnology):
“General practitioners don’t have an overview of all com-
mercially available products. The same goes for nursing
facilities.”
P4, Business, Software developer: “If care partners need
it [GPS technology], where do they go? Where can you
buy it? You won’t find it in a supermarket or media store!
You first have to research it and if you’re not from this
line of work, it’s hard [to find information].”
Furthermore, the low technological affinity of most
end-users was expressed by research and healthcare
professionals.
P18, Research, Project manager (gerontology): “There
are certainly older adults that are good with technologies,
which have smartphones. But there are some older adults
that have no experience—that are technology skeptic.”
(ii) Technological limitations. Technological
limitations causing usage-related difficulties also
lead to low adoption by not satisfying the expect-
ation that use could help increase quality of life. Re-
search professionals reported on their experience
with products that do not provide reliable and ac-
curate location based on poor network communica-
tion issues, frequent hiccups, and product
maintenance updates.
P22, Research, Research associate (gerontechnology):
“When one enters an underground parking lot or a build-
ing, then you can often pretty much forget about location.
The product has to be more than 150% reliable. If not,
you can forget it!”
P22, Research, Research associate (gerontechnology):
“It should be low maintenance … You should be able to
locate immediately, without having to wait for updates.
And if there’s a discrepancy of a few meters and I’m in
the pedestrian zone and there are a lot of people around,
it could be that I don’t find someone who is two meters
away.”
Furthermore, the limited functionality of available
products and poor battery performance were reported as
central technological barriers for all groups.
P5, Business, Marketing analyst: “Geofencing is one as-
pect. I would program other intelligent functions, such as
integrated temperature recognition. There are maybe other
things at persons with dementias’ location that could ac-
tive an alarm. So I would program intelligent systems.”
P1, Business, Company executive: “How long does the
battery last? Since our latest update, max two days … ”
[P4, Business, Software developer: “Max? Yeah, that’s a
problem.”].
(iii)Product characteristic limitations. Regarding the
presented locating device, all groups showed high
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approval for a watch design. However, professionals
emphasized that discrepancies between end-users’
needs and available products would discourage
adoption.
P6, Business, Company executive: “I think I’ve realized
that we have to think a lot more from the perspective of
end-users. This should always be the starting point and
then think about hardware and so forth.”
P2, Business, Company executive: “Persons with de-
mentia and care partners are not our primary market
group.”
Specifically, they expressed the concept of “less is
more”, and the lack of individual configurations that can
adapt to changing healthcare needs with advancing dis-
ease severity.
P12, Healthcare, Healthcare manager: “There is a per-
son with dementia who lives in our nursing facility. He
doesn’t leave the grounds without his fanny pack. If you
could put the product in his fanny pack and it would still
work, that would be ideal.”
P9, Healthcare, Gerontologist: “I find it good that there
are different functions, such as the emergency and two-
way communication. But these functions should be indi-
vidually customizable, looking at actual severity level
and other factors.”
In addition, they stressed that unsatisfactory and stig-
matizing aesthetics due to developing products for het-
erogeneous populations using a one-size-fits-all design
approach or due to technological limitations hinder
adoption.
P11, Healthcare, Managing director of AD society:
“Most products are not aesthetically pleasing for
females.”
P1, Business, Company executive: “The products are
too big! We would gladly reduce the size if the technology
would allow it … The problem is that you need space for
a better battery, for power, for … And so that it’s comfort-
able to wear, particularly if it’s to be worn on the wrist.”
Moreover, product affordability and insufficient infor-
mation on additional costs upon purchase were pivotal
barriers.
P1, Business, Company executive: “The biggest barrier
is always the price.”
P10, Healthcare, Managing director of AD society:
“There’s a cost problem at the moment. Can I afford this?
Are there any additional costs once I use it? Products are
simply too expensive.”
(iv)Capital investment limitations. Business
professionals were the only group to express that
capital investment limitations impacted the
successful development and deployment of high-
quality products. They criticized the collection of
viewpoints on optimal product characteristics with-
out also advocating for higher capital investments
to successfully translate viewpoints to product
development.
P1, Business, Company executive: “There’s no one here
[in the other groups] that I know was involved in product
development, right? There’s a big discrepancy. We could
all say how products should be and what could be done.
But you have to have the money to do this … you first
have to have the money to invest.”
Moreover, they argued for a better follow-through
from research and development phases to product
commercialization.
P1, Business, Company executive: “There are too many
products that are not developed to the end.”
(v) Unclear benefits. Several unclear benefits on the
value of using locating technologies were discussed.
These included end-users not recognizing the need
to use products that can aid with spatial orientation
deficits, utilizing more trusted locating methods
such as involving social network members, and the
limited number of studies using a user-centered de-
sign to better understand end-users’ needs and pref-
erences with unclear information on clinical
effectiveness.
P11, Healthcare, Managing director of AD society:
“Persons with dementia do not see that they need it [lo-
cating device]. At most, care partners recognize a need.”
P5, Business, Marketing analyst: “I [care partners]
might pragmatically get more involved with the [local]
community.”
P21, Research, Research associate (gerontechnology):
“End-users should be more involved [in research and de-
velopment]. They should test products and then we will
better understand what needs to be improved.”
P2, Business, Company executive: “There are dementia
severities, and then it’s always the question: ‘How long
can I [care partners] let persons with dementia move
about and use the product [without studies with persons
with dementia with different AD severities]?”
Also, previous negative experiences with devices could
yield persistent negative perceptions and hinder adop-
tion despite rapidly improving technological innovations.
P1, Business, Company executive: “The technology is
constantly changing. And those [end-users] who did test
it three-four years ago … they had bad experiences. And
if it doesn’t work on the first attempt: Next! Forget it!”
(vi)Ethical concerns. The balance between products
being able to both heighten the autonomous
mobility and infringe on the personal privacy of
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persons with dementia via ubiquitous location
control by care partners or third-party tracking
firms was at the core of the discussion.
P3, Business, Executive associate: “I think of tracking
firms that collect large amounts of data, secretly collect-
ing information on movement profiles … Do we reduce
independence or increase security?”
However, professionals mentioned that care partners’
sense of moral responsibility to provide security for per-
sons with dementia might encourage the adoption of a
security-at-all-costs viewpoint, even if information on
the collection of movement data by third parties is con-
fusing due to unclear data security and privacy aspects.
P19, Research, Project manager (gerontology): “As a
person with dementia, I have my autonomy, I have my
rights. I might not know that I am being located at a par-
ticular time. But for care partners, that’s really not a
problem because they have a sense of security. There’s a
big difference between medical professionals and care
partners, where medical professionals say: ‘That’s an in-
fringement on personal freedom’, and care partners say:
‘I don’t care. I have to know where [person with demen-
tia] is!’”
In addition, research and business professionals added
that changing laws pertaining to legal rights on the loca-
tion of others hinder adoption via slow product develop-
ment and commercialization.
P6, Business, Company executive: “We are very in-
volved with this at the moment. How many movement
profiles can be programmed and saved, under which con-
ditions, etc.? This is a very difficult situation at the mo-
ment for all businesses involved.”
P2, Business, Company executive: “Ultimately, it’s a
legal problem with too many unknowns. Are we allowed
to do this, to do that? This hinders commercialization.
First get approval from a court of law. The external
framework could be better. This is one of the main rea-
sons why it [GPS technologies] has not spread so quickly.”
P15, Research, PhD student (gerontology): “There are
a lot of decisions at the moment on what is allowed re-
garding locating others.”
Services and information dissemination strategies
We identified five recurrent themes on salient services
and information dissemination strategies and 15 sub-
themes, displayed in Table 2, Section 2.
(i) Digital autonomy support. Efforts to support end-
users’ digital autonomy upon product purchase was
a key theme. Discussed ways to support digital au-
tonomy included offering installation and product
training support. Specific examples included provid-
ing at-home installments, product education, web-
based automated technical support to allow end-
users to search for answers to frequently asked
questions and customer support telephone num-
bers, as well as offering case-management support,
where a case manager develops and coordinates a
comprehensive plan of services based on end-users’
needs.
P17, Research, Project manager (health services ad-
ministration): “That you really have an on-location sup-
port that also makes house calls to help one get started
with the product.”
P5, Business, Marketing analyst: “Case-management
service support … If I have a person with deficits, with a
certain problem severity, then I can also offer other at-
tractive service support features.”
P6, Business, Company executive: “ … for example,
that telephone numbers are listed on a website, that fre-
quent questions such as ‘How to install the program’, etc.
are provided.”
However, professionals questioned how the suggested
services could be cost-effectively financed.
P2, Business, Company executive: “But these services
have to be affordable and there are simply too many
older adults that do not have the financial capacity.”
(ii) Emergency support. A second type of service that
was discussed centered on support in emergency
situations. Professionals in all groups agreed that
round-the-clock, external emergency call centers
should be available to provide real-time assistance
should a person with dementia goes missing or if
end-users have more pressing questions.
P17, Research, Project manager (health services ad-
ministration): “It’s important to have an emergency sup-
port call service that answers whatever question you
might have.”
Still, professionals made it clear that providing quality
call centers is fraught with challenges. They cautioned
that such services are notoriously expensive to manage
and that they require a large personnel base.
P6, Business, Company executive: “When an alarm is
set out, because you have personnel changes every 24
hours, you have to have a lot of people that do this [job].
Who does it on the weekends?”
P22, Research, Research associate (gerontechnology):
“Support that is available 24/7 … but this has to be fi-
nanced. That’s also really expensive!”
(iii)Information dissemination actors. Professionals
also discussed the role of several key actors who
could help increase product awareness. Taken
together, a multi-actor approach including memory
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clinics, medical supply stores, general practitioners,
governments, and healthcare insurance companies
was proposed.
P9, Healthcare, Gerontologist: “You could involve
memory clinics.”
P?, Healthcare: “It would be really easy to involve med-
ical supply stores.”
P17, Research, Project manager (health services ad-
ministration): “I think that general practitioners should
be involved because they are typically the starting point.
There’s a trust-based relationship there.”
P19, Research, Project manager (gerontology): “There’s
a pilot project in [German city], where the government
has set up a counselling center also for technology for
older adults … They can advise you there … You can go
to them, but they can also go to you.”
P5, Business, Marketing analyst: “What we need is sup-
port from an established healthcare insurance company
that creates a ‘service-support platform’.”
However, healthcare and research professionals cau-
tioned about the lack of regular follow-ups at memory
clinics, as well as time limitations of general practi-
tioners and potentially harming patient–doctor trust
relationships.
P9, Healthcare, Gerontologist: “But persons with de-
mentia come here [memory clinic] at max every six
months … ”.
P22, Research, Research associate (gerontechnology):
“If my general practitioner talks to me about such prod-
ucts, I’d feel like they are trying to sell me something. I
don’t go to my general practitioner for that.”
P19, Research, Project manager (gerontology): “GPs
are saying: ‘What else are we also supposed to do?’ Who
pays for this extra work?”
(iv)Product acquisition. Furthermore, professionals
discussed which product acquisition methods would
allow to best reach end-users, increase product fa-
miliarity, and facilitate product financing. Main
ideas included promoting retail versus online sales,
offering trial periods at low or no cost, and explor-
ing the role of government subsidies in product
financing.
P19, Research, Project manager (gerontology): “At the
moment, most products can be bought online. So there’s
a lack of vendors with whom older adults can talk to. I
think personal talks are extremely important.”
P12, Healthcare, Healthcare manager: “For me, it
would be a requirement that I can test the product first
for two to three weeks without having to pay a big
amount for this. Maybe a little fee, but not the entire
amount.”
P5, Business, Marketing analyst: “In nursing care, there
are a lot of government care grants … different financial
plans, how you can use these various services.”
(v) Product advertising. Lastly, the role of
promotional activities centering on product
advertising was explored. Key recommendations
included ensuring that advertising messaging and
visuals are non-stigmatizing and that they utilize a
end-user focus. For example, this could be achieved
by emphasizing the value of using products to help
with optimizing the autonomous mobility of per-
sons with dementia rather than focusing on track-
ing features.
P11, Healthcare, Managing director of AD society
(flyer-feedback): “I prefer the description on this flyer. It’s
simple and contains all you need to know … I see secur-
ity, quality of life, liberty. The visual presentation is good,
and the font size is nice and large. This other flyer is not
directed toward persons with dementia, but rather only
toward care partners.”
P3, Business, Executive associate: “We’ve replaced the
word tracking with guardian angel.”
Another suggestion included displaying a seal of qual-
ity from respected research institutions on product ad-
vertisements to optimize end-users’ trust in products.
P1, Business, Company executive: “There have to be in-
stitutions. That’s why I’m here today … In the end, the
Charité or similar is missing. The stamp from ISO does
not suffice. When Charité or German Healthcare Minis-
try is visible, then there’s a completely different quality
level that is achieved.”
Professionals also expected that advertising materials
transparently address key concerns that end-users might
have centering on data security, product characteristics
such as battery life, and service details such as assistance
with emergency situations.
P20, Research, PhD (medical sociology and rehabilita-
tion science): “It could be a marketing problem … for ex-
ample, that it’s not clear that it can be avoided that
everyone sees my data and locate me. If I don’t know
that, I don’t buy it.”
P5, Business, Marketing analyst (flyer feedback): “What
I still don’t know is whether I have to take the watch off
every day and charge it.”
P6, Business, Company executive: “Let’s say I receive a
message at 4am about my mother and this happens three
nights in a row. I’ll be woken up and I can’t really help
… What happens then?”
Furthermore, several examples of advertising platforms
that were viewed as being able to reach end-users more
effectively were mentioned. Identified platforms were
television, magazines, and pharmacies.
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P14, Research, Postdoc (gerontology): “There are prob-
ably people that don’t check online for this [GPS prod-
uct], but rather watch TV. So maybe use TV ads to
multiply information.”
P22, Research, Research associate (gerontechnology):
“I saw an ad in [free magazine with large older adult
readership] about a high blood pressure product. I
thought that was really good. A magazine that a lot of
older adults read—not just persons with dementia and
care partners. And the magazines are free. You can just
take one.”
P14, Research, Postdoc (gerontology): “Maybe there
should just be ads placed in pharmacy windows.”
However, business professionals commented on the
lack of financial resources to promote products on plat-
forms that might better reach end-users.
P1, Business, Company executive: “I don’t produce
million-dollar TV ads.”
Discussion
This study reports on key barriers to the adoption of lo-
cating technologies for use in dementia care, as well as
on services and information dissemination strategies to
increase adoption. Results are relevant for researchers,
healthcare and business professionals, including product
designers and developers as they highlight that adoption
involves more than the technology and products
themselves.
Overall, the professionals in our sample held positive
views on the use of locating technologies as a way to in-
crease end-users’ quality of life. However, these tech-
nologies also raised ethical concerns since they could be
seen as restricting the independence of persons with de-
mentia. Therefore, professionals argued for clear and
transparent information on how the data and movement
profiles of persons with dementia are saved. These find-
ings resonate with previous publications [14, 22, 39].
The mention of these ethical concerns from business
professionals is encouraging as others have argued that
ATs developers pay too little attention to the needs of
end-users or the “human factor” (p. 77) [40]. Also,
participants believed that the need for independence of
persons with dementia and care partners’ need to locate
their loved ones might outweigh data security concerns,
a sentiment expressed by end-users themselves [41].
This finding reinforces the importance of creating
opportunities for collaborations between business
professionals and end-users to ensure that data security
and end-user perspectives are integral to product
development.
The discussion of adoption barriers revealed that the
interplay between barriers is high. For example, low
awareness of the existence of locating technologies by
end-users could in part be attributed to unsuccessful
communication across relevant stakeholders, with lim-
ited research on clinical and cost-effectiveness as a driv-
ing factor behind this association. In turn, limited
research-validated studies on clinical effectiveness dis-
courages healthcare professionals from recommending
locating technologies, and hampers larger societal dis-
courses on their value. Regarding product characteris-
tics, the role of technological innovations to maximize
individualization and reduce the risk of stigmatization
were stressed. Although not explicitly mentioned by pro-
fessionals, we add that technological innovations that
incorporate prominent patterns of AD-related spatial
orientation deficits, such as “dimensions of pattern (lap-
ping, random, or pacing), frequency, [and] boundary
transgressions” (p. 99) [8] could help ensure that locat-
ing technologies better respond to end-users’ needs, de-
sires, and capabilities.
When discussing services, professionals highlighted
that supporting the digital autonomy of end-users to
help counteract low technological affinity, as well as
building trusting relationships with service providers are
essential for adoption. Efforts to support digital auton-
omy to help persons with dementia age-in-place is a
timely topic [42], and several examples on ways to
optimize digital autonomy were provided. We maintain
that services can address end-users’ low technological
experience in real-world scenarios by mimicking clinical
study environments where products are typically ex-
plained and shortly tested before being used for longer
periods of time. Furthermore, while discussing informa-
tion dissemination strategies, professionals provided sev-
eral recommendations for promotional activities to
increase product awareness. Taken together, they indi-
cated that a multi-stakeholder approach is key and advo-
cated the concept of “meeting consumers where they
are” by using traditional sources of information dissem-
ination. Also, they mentioned that offering trial periods
could help end-users gain experience with a product and
enable UX feedback. Indeed, studies show that end-users
are more satisfied with the acquisition of ATs when their
opinions are factored into device recommendations [43].
Feedback on the presented advertisement flyers indi-
cated that product marketing has a large room for im-
provement in terms of content and visuals that can be
achieved by creating marketing tools in a process of co-
creation between persons with dementia, their care part-
ners and business stakeholders. Similar to recent studies
[44, 45], professionals’ stressed the importance of placing
end-users at the center of marketing activities to reduce
stigmatizing keywords and visuals, as well as to ensure
that information on functionality and data security are
transparently and adequately addressed.
This study has some limitations. First, although asking
professionals about their views on the use of locating
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technologies for dementia care might have resulted in
findings reported elsewhere [20, 46], the perspectives of
business professionals are largely lacking in the litera-
ture. Second, the use of a convenience sampling tech-
nique, which was used to ensure that professionals have
sufficient knowledge on the use of locating technologies
for dementia care, might have resulted in the collection
of viewpoints from persons more positively biased to-
ward the use of these technologies. However, other pro-
fessional stakeholders [14, 20] similarly report high
openness toward the use of ATs in dementia care. Still,
the possibility of a positive bias cannot be conclusively
ruled out, particularly since 22 out of the 70 profes-
sionals contacted agreed to participate. However, as pre-
viously mentioned, the focus groups generated rich and
diverse viewpoints and low recruitment rates using e-
mail is typical [47]. Third, the finding that recommenda-
tions regarding product pricing were not explicitly dis-
cussed in the third section although purchase cost was
mentioned as a pivotal barrier for product adoption can
be seen as a limitation. This limitation is not unique to
our work, and past research with end-users also gener-
ally reports a high range of acceptable purchase costs
which typically range from 20 to 100 dollars [44]. Still,
the fact that product pricing was not explicitly discussed
is one example that points to a larger limitation of this
study. Upon closer analysis of professionals’ quotes in
the second and third sections of the focus group inter-
view, we find that they are largely opinion-based rather
than experience-based. Given that we used purposive
sampling and that we encouraged professionals to report
on their own experiences, this finding suggests that
some of the included professional stakeholders may have
limited experience on the use of locating technologies
for dementia care. Quite revelatory is that at least one
business professional explicitly mentioned that persons
with dementia and their care partners are not their pri-
mary market group. The development and marketing of
locating technologies for dementia care that meets end-
users’ needs, preferences and values requires a funda-
mental paradigm shift insofar as this will take time, and
will require a end-user focus and a process of co-
creation between end-users and professional stake-
holders to optimize long-term product adoption. As
mentioned by one business professional, dynamic indi-
viduals with the financial capital and drive to embark on
this quest are needed. Also, a lack of relevant profes-
sional expertise, particularly by business professionals,
increases the risk of developing and marketing products
that end-users perceive as being stigmatizing. Finally, the
fact that the discussion took place a few years ago may
be seen as a limitation to the present findings. Yet, from
what could be found from the scientific literature, no
significant changes in the uptake of locating technologies
by end-users has occurred since the study was per-
formed, suggesting that adoption barriers have not been
adequately addressed.
The strengths of the present study include its qualita-
tive nature to allow for an in-depth exploration of a
complex and multifaceted topic [30], as well as its inter-
disciplinary nature by bringing together stakeholders
with different areas of expertise. While others have
argued that “multiple stakeholders with differing
philosophical viewpoints slow the development,
commercialization and deployment of geriatric technolo-
gies” (p. 80) [48], our results do not support this view. A
key recommendation based on the results of the current
study is to provide opportunities for collaborations be-
tween end-users and interdisciplinary stakeholders to
support the development and commercialization of
scientifically-validated, clinically effective locating tech-
nologies for dementia care [49]. Also, and to our know-
ledge, the inclusion of business professionals is new.
Business professionals proved to be particularly helpful
in understanding business-related topics and hurdles
since they provided more examples of service recom-
mendations, were the only group to mention the role of
government subsidies in product financing, as well as
capital investment limitations impacting the develop-
ment and deployment of high-quality products. In
addition, studies addressing marketing strategies for lo-
cating technologies for dementia care are rare [44] even
though marketing aspects play a central role in product
adoption [26, 27]. Lastly, the focus on locating technolo-
gies can be viewed as a strength as viable solutions to in-
crease adoption are still largely limited to extrapolating
findings from a broad range of ATs with various
applications.
Conclusions
In conclusion, this paper resonates with past findings on
adoption barriers, and identifies services and information
dissemination factors that remain to be adequately ad-
dressed before the implementation of locating technolo-
gies can truly make a difference in dementia care. The
need to improve locating solutions and their adoption
has been highlighted by the recent creation of inter-
national and interdisciplinary consortiums and networks
[50, 51]. Moving forward, collaborations between end-
users and professional stakeholders that examine what
services end-users find appropriate to increase digital au-
tonomy, and what information dissemination strategies
to utilize to effectively reach end-users are steps in the
right direction.
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